Glucag0n
Product Images NDC 51662-1323

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glucag0n (NDC 51662-1323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinical A (Clinical Pharma A)

FDA Label Image

Clinical B (Clinical Pharma B)

FDA Label Image

Dosage (Dosage Table)

Dosage (Dosage Table)
This text provides a table of information about the different doses, routes of administration, time of onset, and duration of effect for a medication. The medication is not specified.*
FDA Label Image

Image 1 (Ifu 1)

FDA Label Image

Image 2 (Ifu 2)

FDA Label Image

Image 3 (Ifu 3)

FDA Label Image

Image 4 (Ifu 4)

FDA Label Image

Table 1 (Ifu Table 1)

Table 1 (Ifu Table 1)
This text describes various symptoms related to a medical condition, including sweating, drowsiness, dizziness, sleep disturbances, palpitation, anxiety, tremor, blurred vision, hunger, slurred speech, restlessness, depressed mood, tingling in the hands, feet, lips, or tongue, irritability, lightheadedness, abnormal behavior, inability to concentrate, unsteady movement, headache, and personality changes.*
FDA Label Image

Table 2 (Ifu Table 2)

Table 2 (Ifu Table 2)
This is a list of symptoms that can occur due to various health conditions. These symptoms include disorientation, seizures, unconsciousness, and even death in severe cases. Without additional context, it is not possible to determine the specific cause of these symptoms.*
FDA Label Image

Label 1 (Label 1)

Label 1 (Label 1)
The text describes a Glucagon Emergency Kit with product details and manufacturing locations. The kit includes Glucagon for Injection, which is prescribed for low blood sugar. The diluting syringe is manufactured in Germany. Therefore, it is a medication used in emergency situations to increase blood sugar levels.*
FDA Label Image

Label 2 (Label 2)

FDA Label Image

Serialized Label (Serialized Label)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.